A carregar...
Exploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting
PURPOSE: Symptomatic adverse event (AE) monitoring is essential in cancer clinical trials to assess patient safety, as well as inform decisions related to treatment and continued trial participation. As prior research has demonstrated that conventional concordance metrics (e.g., intraclass correlati...
Na minha lista:
| Publicado no: | J Cancer Res Clin Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5354957/ https://ncbi.nlm.nih.gov/pubmed/28093637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-016-2335-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|